Ongoing clinical trials involving direct targeting of KRAS. | Download Scientific Diagram
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity | Nature
Selective KRAS G12C inhibitors in non-small cell lung cancer: chemistry, concurrent pathway alterations, and clinical outcomes | npj Precision Oncology
The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature
Mixed data: AMG 510 in tumours with KRASG12C - Medical Conferences
Enhanced binding of AMG 510 to KRAS(G12C) results in improved... | Download Scientific Diagram
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
KRAS(G12C)–AMG 510 interaction dynamics revealed by all-atom molecular dynamics simulations | Scientific Reports
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity | Nature
Frontiers | The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
Deconstructing the KRAS+ market opportunity
Understanding the influence of AMG 510 on the structure of KRASG12C empowered by molecular dynamics simulation - ScienceDirect
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity | Nature
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity | Nature
Cancers | Free Full-Text | Targeting KRAS in Cancer: Promising Therapeutic Strategies
KRAS(G12C)–AMG 510 interaction dynamics revealed by all-atom molecular dynamics simulations | Scientific Reports
KRAS Inhibitor Shows Promise in Early Trial - NCI
The Discovery Of Amgen's Novel Investigational KRASG12C Inhibitor AMG 510
Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors | Journal of Medicinal Chemistry
Sotorasib - Wikipedia
Amgen unveils its KRas inhibitor in human clinical trials
AMG 510 covalently modifies KRAS(G12C) in tumours and inhibits... | Download Scientific Diagram
RSC Medicinal Chemistry
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity | Nature
Cancer Drug Discovered with ALS Help Enters Phase 2 Trials - Biosciences Area
